DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 47 filers reported holding DEPOMED INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,851,000 | -83.2% | 2,500,000 | -80.0% | 0.00% | -85.7% |
| Q2 2017 | $11,015,000 | -9.6% | 12,500,000 | -3.8% | 0.02% | -8.7% |
| Q1 2017 | $12,187,000 | +18.5% | 13,000,000 | +44.4% | 0.02% | +9.5% |
| Q4 2016 | $10,282,000 | -53.6% | 9,000,000 | -42.0% | 0.02% | -52.3% |
| Q3 2016 | $22,147,000 | +1.6% | 15,515,000 | -13.8% | 0.04% | -4.3% |
| Q2 2016 | $21,791,000 | +55.1% | 18,000,000 | +20.0% | 0.05% | +48.4% |
| Q1 2016 | $14,053,000 | -0.2% | 15,000,000 | +21.5% | 0.03% | -3.1% |
| Q4 2015 | $14,079,000 | +7.3% | 12,350,000 | +12.2% | 0.03% | +3.2% |
| Q3 2015 | $13,122,000 | +4.0% | 11,004,000 | +11.7% | 0.03% | +19.2% |
| Q2 2015 | $12,619,000 | +12.3% | 9,849,000 | +15.9% | 0.03% | +8.3% |
| Q1 2015 | $11,235,000 | +990.8% | 8,500,000 | +790.1% | 0.02% | +1100.0% |
| Q4 2014 | $1,030,000 | -82.8% | 955,000 | -83.2% | 0.00% | -84.6% |
| Q3 2014 | $5,990,000 | – | 5,675,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 5,500,000 | $4,633,000 | 2.75% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 27,019,000 | $22,776,000 | 0.90% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,500,000 | $10,563,000 | 0.80% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 51,016,000 | $42,853,000 | 0.76% |
| UBS OCONNOR LLC | 41,000,000 | $34,203,000,000 | 0.61% |
| Man Investments (CH) AG | 600,000 | $508,000 | 0.48% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 20,534,000 | $17,398,000 | 0.33% |
| Senvest Management, LLC | 5,000,000 | $4,228,000 | 0.30% |
| CQS Cayman LP | 4,706,000 | $4,036,000 | 0.26% |
| CSS LLC/IL | 4,436,000 | $3,755,000 | 0.18% |